Table 2.
Effect of evidence-based secondary prevention medication levels on vascular outcomes and all-cause mortality at 2 years in populations after recent noncardioembolic stroke

Effect of evidence-based secondary prevention medication levels on vascular outcomes and all-cause mortality at 2 years in populations after recent noncardioembolic stroke
